Irinotecan topotecan. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Cell Line, Tumor

Organisms1

Diseases25

Colorectal Neoplasms Neutropenia Carcinoma, Small Cell Ovarian Neoplasms Lung Neoplasms Diarrhea Neoplasms Neoplasm Recurrence, Local Leukopenia Neoplasm Metastasis Small Cell Lung Carcinoma Nausea Rhabdomyosarcoma Thrombocytopenia Adenocarcinoma Brain Neoplasms Vomiting Neuroblastoma Peritoneal Neoplasms Hematologic Diseases Colonic Neoplasms Glioma Mucositis Retinal Neoplasms Disease Progression

Chemicals and Drugs31

Topotecan Camptothecin Topoisomerase I Inhibitors Antineoplastic Agents, Phytogenic Antineoplastic Agents Leucovorin Fluorouracil Organoplatinum Compounds DNA Topoisomerases, Type I Glucuronosyltransferase Cisplatin Carboxylesterase Topoisomerase Inhibitors Deoxycytidine Antibodies, Monoclonal, Humanized Paclitaxel Etoposide Antimetabolites, Antineoplastic Glucuronates Prodrugs ATP-Binding Cassette Transporters Carboplatin Thiophenes Acridines Glucuronides Antibodies, Monoclonal Quinazolines Enzyme Inhibitors Tegafur Taxoids Oxonic Acid

Analytical, Diagnostic and Therapeutic Techniques and Equipment17

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Infusions, Intravenous Maximum Tolerated Dose Treatment Outcome Area Under Curve Survival Analysis Administration, Oral Salvage Therapy Disease-Free Survival Survival Rate Xenograft Model Antitumor Assays Drug Screening Assays, Antitumor Clinical Trials, Phase II as Topic Neoplasm Staging Administration, Metronomic Metabolic Clearance Rate

Phenomena and Processes8

Maximum Tolerated Dose Area Under Curve Dose-Response Relationship, Drug Drug Resistance, Neoplasm Drug Synergism Convection Drug Interactions Metabolic Clearance Rate

Disciplines and Occupations1

Pharmacogenetics

Information Science1

Health Care6

Treatment Outcome Area Under Curve Survival Analysis Disease-Free Survival Survival Rate Clinical Trials, Phase II as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Topotecan Camptothecin Topoisomerase I Inhibitors Antineoplastic Agents, Phytogenic Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Antineoplastic Agents Infusions, Intravenous Colorectal Neoplasms Leucovorin Fluorouracil Organoplatinum Compounds Maximum Tolerated Dose Neutropenia DNA Topoisomerases, Type I Glucuronosyltransferase Treatment Outcome Cisplatin Area Under Curve Carboxylesterase Dose-Response Relationship, Drug Topoisomerase Inhibitors Carcinoma, Small Cell Ovarian Neoplasms Deoxycytidine Lung Neoplasms Diarrhea Drug Resistance, Neoplasm Neoplasms Antibodies, Monoclonal, Humanized Survival Analysis Neoplasm Recurrence, Local Administration, Oral Salvage Therapy Leukopenia Neoplasm Metastasis Small Cell Lung Carcinoma Nausea Rhabdomyosarcoma Disease-Free Survival Survival Rate Thrombocytopenia Adenocarcinoma Paclitaxel Drug Synergism Brain Neoplasms Etoposide Antimetabolites, Antineoplastic Glucuronates Xenograft Model Antitumor Assays Vomiting Prodrugs Neuroblastoma Convection ATP-Binding Cassette Transporters Carboplatin Drug Screening Assays, Antitumor Cell Line, Tumor Peritoneal Neoplasms Clinical Trials, Phase II as Topic Hematologic Diseases Mice, Nude Pharmacogenetics Colonic Neoplasms Glioma Drug Interactions Thiophenes Mucositis Retinal Neoplasms Acridines Glucuronides Antibodies, Monoclonal Neoplasm Staging Quinazolines Enzyme Inhibitors Tegafur Administration, Metronomic Metabolic Clearance Rate Disease Progression Taxoids Oxonic Acid

No FAQ available that match "irinotecan topotecan"